Veterinary Medicines

ALFADEXX 2 MG/ML SOLUTION FOR INJECTION FOR HORSES, CATTLE, GOATS, PIGS, DOGS AND CATS

Authorised
  • DEXAMETHASONE DISODIUM PHOSPHATE
Download as PDF

Product identification

Medicine name:
ALFADEXX 2 MG/ML SOLUTION FOR INJECTION FOR HORSES, CATTLE, GOATS, PIGS, DOGS AND CATS
Alfadexx 2mg/ml Solution injectable
Alfadexx 2mg/ml Oplossing voor injectie
Alfadexx 2mg/ml Injektionslösung
Active substance:
  • DEXAMETHASONE DISODIUM PHOSPHATE
Target species:
  • Cattle
  • Pig
  • Cat
  • Horse
  • Goat
  • Dog
Route of administration:
  • Intramuscular use
  • Subcutaneous use
  • Periarticular use
  • Intravenous use
  • Intraarticular use

Product details

Active substance and strength:
  • DEXAMETHASONE DISODIUM PHOSPHATE
    2.63
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        8
        day
      • Milk
        72
        hour
    • Pig
      • Meat and offal
        2
        day
    • Cat
    • Horse
      • Meat and offal
        8
        day
      • Milk
        no withdrawal period
    • Goat
      • Meat and offal
        8
        day
      • Milk
        72
        hour
    • Dog
  • Subcutaneous use
    • Dog
    • Cat
  • Periarticular use
    • Horse
      • Meat and offal
        8
        day
      • Milk
        no withdrawal period
  • Intravenous use
    • Cattle
      • Meat and offal
        8
        day
      • Milk
        72
        hour
    • Pig
      • Meat and offal
        6
        day
    • Cat
    • Horse
      • Meat and offal
        8
        day
      • Milk
        no withdrawal period
    • Goat
      • Meat and offal
        8
        day
      • Milk
        72
        hour
    • Dog
  • Intraarticular use
    • Horse
      • Meat and offal
        8
        day
      • Milk
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH02AB02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Available in:
  • Belgium
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Alfasan Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Produlab Pharma B.V.
  • Alfasan Nederland B.V.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V594373
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0430/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 14/03/2025
Download
French (PDF)
Published on: 14/03/2025
Download
German (PDF)
Published on: 14/03/2025
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 14/03/2025
Download
French (PDF)
Published on: 14/03/2025
Download
German (PDF)
Published on: 14/03/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 14/03/2025
Download
French (PDF)
Published on: 14/03/2025
Download
German (PDF)
Published on: 14/03/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."